RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--CivaTech Oncology, Inc., an early stage company developing a novel medical device for the treatment of prostate cancer, has raised $800,000 in an oversubscribed private financing. The Company was founded in 2006 by Robert and Claudia Black (two of the founders of Sicel Technologies) and Suzanne Babcock (former VP of Troxler Electronics) and is headquartered in the Park Research Center in RTP.
